A powerful Senate Republican heralded on Wednesday a slate of policies aimed at lowering the price of prescription medicines — and outlined a clear path forward for passing them into law with bipartisan, bicameral support.

Sen. Chuck Grassley, the Iowa Republican who chairs the Senate Finance Committee, said his “good working relationship” with ranking member Sen. Ron Wyden (D-Ore.), along with his conversations with other key lawmakers in the House and on the Health, Education, Labor, and Pensions Committee, present a “real opportunity” for a collaborative product — brought by both committees to the Senate floor — by the end of this year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy